{"id":11371,"date":"2025-07-26T22:25:42","date_gmt":"2025-07-26T20:25:42","guid":{"rendered":"https:\/\/valintermed.com\/?p=11371"},"modified":"2025-07-26T22:25:42","modified_gmt":"2025-07-26T20:25:42","slug":"glyukagonoma","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/glyukagonoma\/","title":{"rendered":"Glucagonoma"},"content":{"rendered":"
<\/div>\n

Glucagonoma is a rare endocrine tumor process characterized by hypersecretion of glucagon, which leads to the development of various metabolic disorders. Most cases of glucagonoma are associated with the presence of a tumor in the alpha cells of the pancreas. The hormone produced by glucagon promotes an increase in blood glucose levels due to gluconeogenesis and glycogenolysis, which ultimately leads to the development of hyperglycemia. The clinical picture of the disease often includes symptoms associated with insulin deficiency and increased catabolic processes, which can manifest as weight loss, skin rash, and neuropathy. Glucagonoma is usually diagnosed in patients aged 50\u201370 years, but cases occur at earlier and later ages.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n